SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-Dec-22 4:16 PM View: | Quantum-Si Inc (QSI) | 20-Dec-22 | Disposition (other) | 601,000 | -- | -- | (33%) 1.82M to 1.22M | |
16-Dec-22 4:08 PM View: | Quantum-Si Inc (QSI) | 15-Dec-22 | Sale | 89,000 | $2.15 | $191,234.00 | (5%) 1.91M to 1.82M | |
22-Mar-22 8:30 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 21-Mar-22 | Sale | 10,000 | $9.41 | $94,096.00 | (18%) 56.66K to 46.66K | |
22-Feb-22 5:30 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 17-Feb-22 | Payment of Exercise | 3,010 | $10.63 | $31,996.30 | (5%) 59.67K to 56.66K | |
22-Feb-22 5:30 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 17-Feb-22 | Option Exercise | 6,667 | $4.80 | $32,001.60 | 13% 53.0K to 59.67K | |
14-Feb-22 10:00 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 11-Feb-22 | Gift | 5,000 | -- | -- | (10%) 52.0K to 47.0K | |
05-Jan-22 8:35 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 03-Jan-22 | Grant | 6,000 | -- | -- | 12% 52.0K to 58.0K | |
17-Dec-21 5:15 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 16-Dec-21 | Gift | 5,000 | -- | -- | (9%) 57.0K to 52.0K | |
10-Feb-22 10:00 PM View: | Quantum-Si Inc (QSI) | 03-Nov-21 | Gift | 11,000 | -- | -- | (< 1%) 1.92M to 1.91M | |
20-Sep-21 4:01 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 16-Sep-21 | Market Sale | 21,100 | $20.99 | $442,830.00 | (27%) 78.1K to 57.0K | 2% |
02-Sep-21 4:44 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 31-Aug-21 | Grant | 10,000 | -- | -- | 15% 68.1K to 78.1K | |
11-Aug-21 10:00 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 09-Aug-21 | Payment of Exercise | 26,093 | $21.09 | $550,301.00 | (28%) 94.2K to 68.1K | |
11-Aug-21 10:00 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 09-Aug-21 | Option Exercise | 79,136 | $6.95 | $550,315.00 | 525% 15.06K to 94.2K | |
15-Jun-21 5:27 PM View: | Quantum-Si Inc (QSI) | 11-Jun-21 | Grant | 20,512 | -- | -- | 1% 1.9M to 1.92M | |
15-Jun-21 5:27 PM View: | Quantum-Si Inc (QSI) | 10-Jun-21 | Grant | 1,901,000 | $10.00 | $19,010,000.00 | 100% 0 to 1.9M | |
11-Feb-19 4:26 PM View: | Ocugen, Inc. (OCGN) | 08-Feb-19 | Option Exercise | 173,076 | -- | -- | 38% 458.96K to 632.04K | |
11-Feb-19 4:26 PM View: | Ocugen, Inc. (OCGN) | 08-Feb-19 | Option Exercise | 177,777 | -- | -- | 28% 632.04K to 809.82K | |
11-Oct-18 4:30 PM View: | Ocugen, Inc. (OCGN) | 10-Oct-18 | Purchase | 230,768 | -- | -- | 101% 228.2K to 458.96K | |
07-Dec-16 11:11 AM View: | Oramed Pharmaceuticals Inc. (ORMP) | 06-Dec-16 | Grant | 3,300 | $6.59 | $21,762.80 | 28% 11.76K to 15.06K | |
07-Dec-16 11:11 AM View: | Oramed Pharmaceuticals Inc. (ORMP) | 05-Dec-16 | Grant | 2,300 | $6.38 | $14,665.00 | 24% 9.46K to 11.76K | |
05-Dec-16 2:24 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 02-Dec-16 | Grant | 7,261 | $6.21 | $45,057.40 | 330% 2.2K to 9.46K | (28%) |
05-Dec-16 2:24 PM View: | Oramed Pharmaceuticals Inc. (ORMP) | 01-Dec-16 | Grant | 2,200 | $6.08 | $13,370.90 | 100% 0 to 2.2K | |
02-Dec-16 5:00 PM View: | Ocugen, Inc. (OCGN) | 30-Nov-16 | Conversion | 142,396 | -- | -- | 42% 337.5K to 479.89K | |
03-Oct-16 5:15 PM View: | Ocugen, Inc. (OCGN) | 29-Sep-16 | Grant | 35,381 | $2.25 | $79,607.20 | 21% 171.16K to 206.54K | |
08-Dec-14 4:45 PM View: | Ocugen, Inc. (OCGN) | 08-Dec-14 | Conversion | 15,538 | -- | -- | 32% 48.83K to 64.37K | |
08-Dec-14 4:45 PM View: | Ocugen, Inc. (OCGN) | 08-Dec-14 | Conversion | 10,358 | -- | -- | 16% 64.37K to 74.73K | |
08-Dec-14 4:45 PM View: | Ocugen, Inc. (OCGN) | 08-Dec-14 | Disposition (other) | 89 | -- | -- | (< 1%) 86.21K to 86.12K | |
08-Dec-14 4:45 PM View: | Ocugen, Inc. (OCGN) | 08-Dec-14 | Disposition (other) | 58 | -- | -- | (< 1%) 86.12K to 86.06K | |
08-Dec-14 4:45 PM View: | Ocugen, Inc. (OCGN) | 08-Dec-14 | Purchase | 6,742 | $11.00 | $74,162.00 | 9% 74.73K to 81.47K | |
08-Dec-14 4:45 PM View: | Ocugen, Inc. (OCGN) | 08-Dec-14 | Purchase | 4,495 | $11.00 | $49,445.00 | 6% 81.47K to 85.97K | |
08-Dec-14 4:45 PM View: | Ocugen, Inc. (OCGN) | 08-Dec-14 | Sale | 17 | $11.00 | $187.00 | (< 1%) 86.06K to 86.05K | |
08-Dec-14 4:45 PM View: | Ocugen, Inc. (OCGN) | 08-Dec-14 | Exercise (in-the money or at-the-money) | 242 | $0.76 | $183.92 | < 1% 85.97K to 86.21K | |
12-Dec-08 1:48 PM View: | Vion Pharmaceuticals Inc. (VION.OB) | 11-Dec-08 | Grant | 1,130 | -- | -- | 19% 6.1K to 7.23K | |
05-Sep-08 3:44 PM View: | Omrix Biopharmaceuticals, I... (OMRI) | 04-Sep-08 | Grant | 2,000 | -- | -- | 50% 4.0K to 6.0K | |
28-Mar-08 2:27 PM View: | Omrix Biopharmaceuticals, I... (OMRI) | 26-Mar-08 | Market Purchase | 2,000 | $13.65 | $27,296.30 | 100% 2.0K to 4.0K | 15% |
28-Jun-07 7:56 PM View: | Vion Pharmaceuticals Inc. (VION.OB) | 27-Jun-07 | Grant | 11,300 | -- | -- | 23% 49.7K to 61.0K | |
01-Jun-07 11:20 AM View: | Omrix Biopharmaceuticals, I... (OMRI) | 31-May-07 | Grant | 2,000 | -- | -- | 100% 0 to 2.0K | |
15-Mar-07 11:48 AM View: | Vion Pharmaceuticals Inc. (VION.OB) | 13-Mar-07 | Market Purchase | 15,000 | $1.59 | $23,850.00 | 43% 34.7K to 49.7K | (87%) |
17-Jan-07 7:02 PM View: | Vion Pharmaceuticals Inc. (VION.OB) | 15-Jan-07 | Grant | 34,700 | -- | -- | 100% 0 to 34.7K | |
27-Nov-06 4:20 PM View: | Clinical Data, Inc. (CLDA) | 20-Nov-06 | Market Sale | 10,000 | $16.18 | $161,815.00 | (22%) 46.43K to 36.43K | 23% |
22-Aug-06 12:02 PM View: | Clinical Data, Inc. (CLDA) | 08-Aug-06 | Gift | 540 | -- | -- | (1%) 46.97K to 46.43K | |
21-Nov-05 8:02 PM View: | Clinical Data, Inc. (CLDA) | 17-Nov-05 | Grant | 2,500 | $19.56 | $48,906.20 | 6% 44.47K to 46.97K | (36%) |
06-Oct-05 9:21 PM View: | Genaissance Pharmaceuticals... (GNSCE.PK) | 06-Oct-05 | Disposition | 584,094 | -- | -- | (85%) 684.09K to 100.0K | |
06-Oct-05 9:21 PM View: | Genaissance Pharmaceuticals... (GNSCE.PK) | 06-Oct-05 | Disposition | 100,000 | -- | -- | (100%) 100.0K to 0 | |
21-Jan-05 1:42 PM View: | Genaissance Pharmaceuticals... (GNSCE.PK) | 07-Jan-05 | Grant | 35,000 | $0.00 | $35.00 | 5% 657.39K to 692.39K | |
29-Apr-04 10:00 PM View: | Genaissance Pharmaceuticals... (GNSCE.PK) | 23-Feb-04 | Gift | 2,500 | -- | -- | (< 1%) 659.89K to 657.39K |